CLINICAL_TRIALS
research
· 2016-04-20
Clinical Trial Update: Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. [Phase 2]
Summary
A Phase 2 clinical trial is evaluating Endostatin in combination with Oxaliplatin and radiotherapy for esophageal cancer; the trial's status is currently unknow…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hangzhou Cancer Hospital | Conditions: Esophageal Cancer, Endostatin | Phase 2 | Status: UNKNOWN